When the marketing authorisation does not categorise a substance as an “active ingredient”, there is a rebuttable presumption that this substance has no pharmacological,

immunological or metabolic action of its own covered by the therapeutic indications of said marketing authorisation. [...]

This article addresses the overlooked barrier of accountability in the localization of international aid and development. It argues that the conventional monitoring and evaluation

(M&E) practices, designed to satisfy donor accountability, hinder genuine localization in conflict-affected settings. [...]

This contribution is the fruit of numerous discussions with several practitioners and legal advisors within sports organisations in Switzerland, the United Kingdom and the

United States, and aims to guide sports federations in the internal rules they must put in place following the recommendations of the International Olympic Committee [...]

The Court of Justice of the European Union (E.U.) is sometimes labelled “a teleological court”. In this paper I will show why it is a misleading label. Then I will propose

a more appropriate label for it – “a contextualist court” – and describe what such a label reveals about the interpretation of E.U. [...]

When policymakers and officials conceive of some law or regulation designed to criminal, deviant, or socially undesirable behaviors, the best-case scenario is not that it works

as intended but that it surpasses original expectations. Similarly, the worst-case scenario is not that the law fails to achieve its intended effect but that it does [...]

In Intellectual Property and Immorality: Against Protecting Harmful Creations of the Mind,11 Professor Ned Snow argues that patent and copyright protection should not be granted

for certain inventions and creations that are harmful to individuals and society. [...]